ACRS Competitors & Alternatives
Compare Aclaris Therapeutics Inc with similar stocks in the same industry
Biotechnology
ACRS
Main Stock$4.32
Tradestie Score
57
Market Cap
$202.58M
Revenue Growth
0.4%
Analyst Upside
+123.8%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$36.44
|
$715.25M | - | 57 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 59 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$109.47
|
$699.30M | - | 60 | Compare |
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$6.53
|
$688.47M | - | 45 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 57 | Compare |
|
ARVN
Arvinas, Inc
|
$8.91
|
$670.30M | - | 45 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$9.57
|
$665.30M | - | 55 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$10.34
|
$626.91M | - | 50 | Compare |
|
SVRA
Savara Inc.
|
$5.14
|
$611.84M | - | 57 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$26.75
|
$608.81M | - | 62 | Compare |
More ACRS Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry